Author Title [ Type(Desc)] Year
Filters: Author is Mack, David L  [Clear All Filters]
Journal Article
J Pioner M, Guan X, Klaiman JM, Racca AW, Pabon L, Muskheli V, Macadangdang J, Ferrantini C, Hoopmann MR, Moritz RL, et al. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human induced pluripotent stem cells. Cardiovasc Res. 2019.
Berry BJ, Smith AST, Young JE, Mack DL. Advances and Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cells in Modeling Neurodegenerative Disease. Cells Tissues Organs. 2018:1-19.
Mack DL, Guan X, Wagoner A, Walker SJ, Childers MK. Disease-in-a-Dish: The Contribution of Patient-Specific Induced Pluripotent Stem Cell Technology to Regenerative Rehabilitation. Am J Phys Med Rehabil. 2014.
Boulanger CA, Bruno RD, Mack DL, Gonzales M, Castro NP, Salomon DS, Smith GH. Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. PLoS One. 2013;8(4):e62019.
Braun R, Wang Z, Mack DL, Childers MK. Gene Therapy for Inherited Muscle Diseases: Where Genetics Meets Rehabilitation Medicine. Am J Phys Med Rehabil. 2014;93(11 Suppl 3):S97-S107.
Guan X, Goddard MA, Mack DL, Childers MK. Gene therapy in monogenic congenital myopathies. Methods. 2015.
Goddard MA, Mack DL, Czerniecki SM, Kelly VE, Snyder JM, Grange RW, Lawlor MW, Smith BK, Beggs AH, Childers MK. Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy. Ann Transl Med. 2015;3(18):262.